一种新的四面体框架核酸衍生的化学动力学治疗剂,用于有效治疗质母细胞瘤
Xiaodie Li1, Lei Li2, Xin Fu1
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Cell proliferation
|August 24, 2024
概括
一种新型化学动力学治疗 (CDT) 剂Fe@tFNAs-ANG-3AT通过穿越血脑屏障并增加过氧化水平以增强瘤细胞杀死,有效地向质母细胞瘤 (GBM).
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 化学动力学疗法 (CDT) 由于其局部作用和减少副作用,对癌症治疗具有前景.
- 质母细胞瘤 (GBM) 治疗是具有挑战性的,原因是血脑屏障 (BBB),瘤向不良,以及瘤微环境 (TME) 中低过氧化 (H2O2) 水平.
研究的目的:
- 开发一种新的CDT剂 (Fe@tFNAs-ANG-3AT),能够克服当前GBM疗法的局限性.
- 增强BBB透,瘤向和H2O2可用性,以提高GBM中的CDT疗效.
主要方法:
- 使用四面体框架核酸 (tFNA) 制造Fe@tFNAs-ANG-3AT,这些核酸与Angiopep-2 (ANG) 和3-Amino-1,2,4-triazole (3AT) 功能化.
- ANG促进了BBB交叉和瘤细胞向,而3AT提高了H2O2水平.
- 装载在tFNA上的铁离子 (Fe3+) 通过TME中的谷氨 (GSH) 减少到Fe2+,催化细胞毒基 (·OH) 的产生.
主要成果:
- Fe@tFNAs-ANG-3AT证明了有效的BBB透和选择性的瘤细胞吸收.
- 该药物成功增加了H2O2水平,并在瘤细胞内产生OH基.
- 由Fe@tFNAs-ANG-3AT引起的高氧化应激导致显著的瘤细胞死亡.
结论:
- Fe@tFNAs-ANG-3AT代表了一种有前途的纳米药物,可以克服GBM治疗的挑战.
- 这种新型的CDT药物有可能成为质母细胞瘤的变革性治疗策略.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


